G1 Therapeutics Inc (GTHX)
7.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 18, 16:00
G1 Therapeutics Gross Profit Margin (Quarterly): 95.57% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 95.57% |
| March 31, 2024 | 92.55% |
| December 31, 2023 | 91.56% |
| September 30, 2023 | 74.99% |
| June 30, 2023 | 96.69% |
| March 31, 2023 | 88.73% |
| December 31, 2022 | 90.32% |
| Date | Value |
|---|---|
| September 30, 2022 | 95.29% |
| June 30, 2022 | 90.77% |
| March 31, 2022 | 90.31% |
| December 31, 2021 | 93.55% |
| September 30, 2021 | 87.83% |
| June 30, 2021 | 87.76% |
| March 31, 2021 | 98.29% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
74.99%
Minimum
Sep 2023
98.29%
Maximum
Mar 2021
91.01%
Average
91.16%
Median
Gross Profit Margin (Quarterly) Benchmarks
| PetIQ Inc | 26.84% |
| Biomarin Pharmaceutical Inc | 74.73% |
| Regeneron Pharmaceuticals Inc | 86.80% |
| Verrica Pharmaceuticals Inc | -- |
| Terns Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -118.9% |
| Return on Assets | -37.11% |
| Return on Invested Capital | -52.13% |
| Profit Margin (Quarterly) | -33.05% |
| Operating Margin (Quarterly) | -21.36% |
| Return on Net Operating Assets | -140.4% |